Amyotrophic Lateral Sclerosis (ALS)

DBCOND0029898Disease and Non-Disease Concepts, UnclassifiedMusculoskeletal and Connective Tissue Diseases

Amyotrophic Lateral Sclerosis (ALS) is the indication for 5 drugs in DrugBank. It is covered by 7 curated, structured indications.

Also known as
Amyotrophic Lateral Sclerosis · ALS · Lou Gehrig's Disease · ALS (Amyotrophic Lateral Sclerosis) · Lou Gehrigs Disease
Classified under
Indicated drugs

Resolves to

Vocabularies
MeSHM0001056ICD-10G12.21SNOMED CT86044005MedDRA10002026UMLSC0002736

What you can answer from here — as of September 29, 2026

5Indicated drugsWith each drug's targets and mechanism
Listed above
7Structured indicationsPopulation, line of therapy, route and combination as fields, not prose
Sign in
477Clinical trialsPhase, status and sponsor resolved per trial
Sign in
5Drugs reporting it as an adverse effectWith incidence where the label states it
Sign in

Which approved drugs for Amyotrophic Lateral Sclerosis (ALS) share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In